Robert R Redfield III, MD, FACS
- Division of Transplantation
600 Highland Ave.
Madison, WI 53792-3284
- MD, Magna Cum Laude, University of Maryland School of Medicine, Baltimore, MD, 2006
- Internship, Hospital of the University of Pennsylvania, Philadelphia, PA, 2007
- Transplant Immunobiology Research Fellowship, Harrison Department of Surgical Research, University of Pennsylvania, Philadelphia, PA, 2011
- Surgery Residency, Hospital of the University of Pennsylvania, Philadelphia, PA, 2013
- Transplantation Fellowship, University of Wisconsin Hospital and Clinics, Madison, WI, 2013-2015
Dr. Redfield is certified by the American Board of Surgery and is a ASTS and UNOS certified transplant surgeon. He specializes in pancreatic, islet cell, and multi-organ transplants as well as vascular access.
Dr. Redfield provides a wide range of services including Kidney Transplant, Laparoscopic Donor Nephrectomy, Pancreas Transplant, Robotic Donor Nephrectomy, “Scarless” Single-Port Laparoscopic Donor Nephrectomy.
Dr. Redfield’s research interests are centered on developing novel strategies to improve long-term allograft survival.
- Renal autotransplantation results in pain resolution after left renal vein transposition.
- Bath NM, Al-Qaoud T, Williams DH, Sollinger HW, Redfield RR
- J Vasc Surg Venous Lymphat Disord 2019 Jul 16;
- [PubMed ID: 31324550]
- Evaluation of infectious risk and outcomes in the hmong renal transplant population.
- Jorgenson MR, Cardinale B, Descourouez JL, Yang DY, Leverson GE, Parajuli S, Smith JA, Redfield RR
- Transpl Infect Dis 2019 Jul 08; e13142
- [PubMed ID: 31283867]
- The Abdominal Transplant Surgery Workforce: Current state and future trends.
- Kaldas FM, Rocca JP, Bhati CS, Duan N, Evenson AR, Tan HP, Redfield RR, di Sabato DM, Yoshida A, Abt PL, Geevarghese SK
- Clin Transplant 2019 Jul 06; e13659
- [PubMed ID: 31278776]
- Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.
- Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D
- Am. J. Transplant. 2019 Jul 01;
- [PubMed ID: 31257724]
- Significant Reduction of Murine Renal Ischemia-Reperfusion Cell Death Using the Immediate-Acting PrC-210 Reactive Oxygen Species Scavenger.
- Bath NM, Fahl WE, Redfield RR
- Transplant Direct 2019 Jul; 5(7): e469
- [PubMed ID: 31334343]